Capacity Increases with 12 Additional Growing Rooms Approved at Domestic Production Facility

TORONTO , May 19, 2015 /CNW/ - Bedrocan Cannabis Corp. (BED.V) ("Bedrocan" or the "Company") announced today that its wholly-owned subsidiary, Bedrocan Canada Inc., has received approval from Health Canada to activate 12 additional growing rooms at its domestic facility, for the production of medicinal cannabis under the Marihuana for Medicinal Purposes Regulations ("MMPR"). To date, 18 of a total of 34 production rooms, as well as the trimming and drying rooms, have now been inspected and licensed.  When fully licensed by Health Canada, the facility is capable of producing approximately 4,000 kg of medicinal cannabis per year.

Under special import permits from Health Canada and the Canadian Food Inspection Agency, Bedrocan has imported approximately 2,000 live genetic clones from the Company's licensing partner Bedrocan BV in the Netherlands . The Company has successfully transferred this know-how and "mothered" its...